- AI Development
- Data Science & Engineering
- Web Development
- Software Quality Assurance
- Medical Image Grading
- IT
- Project Management
- Quality Management & Regulatory Affairs
- Product
- Marketing
- Clinical Operations / Study Management
- Finance
- People & Culture
Speculative Application
Vienna
Full or part-time
Permanent employee
Your responsibilities
Your responsibilities will depend on the role. Areas where we might need support are:
Your profile
Characteristics that distinguish you are:
- You like to work in an international team that values diversity
- You have a hands-on approach
- You like to contribute your own ideas
- You value flat hierarchies
Benefits
- Room for your own ideas and possibility to grow in your role
- Friendly and supportive team culture that values diversity
- Public transport support (Vienna annual pass reimbursed)
- Hybrid work model (home office + in-person collaboration)
- Flexible working hours for better work–life balance
- Central Vienna office, easy to reach by public transport
- Regular team-building activities
- Fully stocked kitchen with snacks and drinks
- Access to digital mental well-being support
- Discounts at selected pharmacies
- Corporate Benefits with offers from various brands
- Buddy program to help you get started
Contact
Interested in joining our team? Then apply now directly or by e-mail to career@retinsight.com! We are looking forward to your speculative application (including CV & motivation letter).
About us
We are a spin-off of the Medical University of Vienna with the aim to bring the breakthroughs of science to the society and each individual, anywhere and anytime. Our expertise builds on more than 15 years of tele-ophthalmology and AI-based retinal image analysis. As pioneers in the field, we are developing cloud-based transformational AI solutions to improve patient outcomes, empower physicians to increase clinical efficiency and reduce healthcare costs addressing the leading eye diseases of our times. With your contribution we will protect millions of patients from irreversible vision loss and blindness.